$3.23 0.00 (0%)
11/27/2009 1:00 PM

DepoMed, Inc. (DEPO)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Featured Broker Partners